ChemoTech attains progress by obtaining patent protection for two essential patents in India
Scandinavian ChemoTech AB today announces that it has been granted two significant patent approvals by The Patent Office, Government of India. This implies that there won't be a requirement to engage in public tenders; rather, a simplified procurement process will be in place. The Patent Office, Government of India has approved two of the Company's patent applications. The now granted patent is a protection of the proprietary TSE technology, specifically, the creation of dynamic pulses, as well as the specialised probe and treatment kits, the protection extends to 2038. It